Elevated preoperative cfDNA levels (> 13.4 ng/mL) and detection of somatic mutations in plasma were associated with shorter PFS and OS, though some associations did not reach statistical significance (Bagley et al. 2019 ).
← all excerpts
From Classical to Emerging Biomarkers of Brain and Central Nervous System Tumors. An Evidence-Based Review with a Focus on Gliomas.
1
—
—